Federated Hermes, Inc. Biotechnology

Federated Hermes, Inc.

$43 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
SAVA Cassava Sciences Inc	$102M	$16,000 0.0% of portfolio	7,100	Q4 2024 New
MRNA Moderna, Inc.	$13.9B	$16,000 0.0% of portfolio	406	Q4 2024 Reduced 81.96%
AADI Aadi Bioscience, Inc.	$58.6M	$14,000 0.0% of portfolio	4,724	Q4 2024 Reduced 2.05%
INZY Inozyme Pharma, Inc.	$50.2M	$14,000 0.0% of portfolio	5,096	Q4 2024 New
TYRA Tyra Biosciences, Inc.	$553M	$14,000 0.0% of portfolio	1,028	Q4 2024 Added 10.54%
ACAD Acadia Pharmaceuticals Inc	$3.23B	$12,000 0.0% of portfolio	699	Q4 2024 Reduced 36.16%
ANTX An2 Therapeutics, Inc.	$21.9M	$10,000 0.0% of portfolio	7,492	Q4 2024 Added 149.23%
ALEC Alector, Inc.	$154M	$9,000 0.0% of portfolio	4,794	Q4 2024 Reduced 85.66%
IMRX Immuneering Corp	$46.5M	$8,000 0.0% of portfolio	3,838	Q4 2024 Reduced 25.26%
OMER Omeros Corp	$576M	$8,000 0.0% of portfolio	810	Q4 2024 Added 385.03%
ALXO Alx Oncology Holdings Inc	$45.6M	$7,000 0.0% of portfolio	4,483	Q4 2024 New
PMVP Pmv Pharmaceuticals, Inc.	$64.3M	$6,000 0.0% of portfolio	4,034	Q4 2024 Reduced 51.07%
XERS Xeris Biopharma Holdings, Inc.	$510M	$6,000 0.0% of portfolio	1,877	Q4 2024 Added 937.02%
ALVR Allovir, Inc.	$896M	$5,000 0.0% of portfolio	13,214	Q3 2024 Reduced 13.24%
RLYB Rallybio Corp	$24.1M	$5,000 0.0% of portfolio	5,991	Q4 2024 Reduced 24.77%
CRBU Caribou Biosciences, Inc.	$79.7M	$4,000 0.0% of portfolio	2,762	Q4 2024 New
RGNX Regenxbio Inc.	$314M	$4,000 0.0% of portfolio	569	Q4 2024 Added 27.87%
TERN Terns Pharmaceuticals, Inc.	$155M	$4,000 0.0% of portfolio	783	Q4 2024 Added 62.11%
ATNM Actinium Pharmaceuticals, Inc.	$29.5M	$3,000 0.0% of portfolio	2,743	Q4 2024 Added 37.15%
ALLK Allakos Inc.	$24.6M	$3,000 0.0% of portfolio	3,194	Q4 2024 Reduced 66.77%
VOR Vor Biopharma Inc.	$52.1M	$3,000 0.0% of portfolio	3,045	Q4 2024 Reduced 18.99%
EWTX Edgewise Therapeutics, Inc.	$1.71B	$2,000 0.0% of portfolio	107	Q4 2024 Reduced 1.83%
BTAI Bio Xcel Therapeutics, Inc.	$59.7M	$1,000 0.0% of portfolio	4,819	Q3 2024 Reduced 90.41%
BCAB Bio Atla, Inc.	$14.9M	$1,000 0.0% of portfolio	1,769	Q3 2024 Reduced 52.52%
KYMR Kymera Therapeutics, Inc.	$2.01B	$1,000 0.0% of portfolio	32	Q4 2024 Reduced 99.52%
NKTR Nektar Therapeutics	$174M	$1,000 0.0% of portfolio	1,256	Q4 2023 Reduced 25.06%
ATHA Athira Pharma, Inc.	$16.3M	$0 0.0% of portfolio	1,014	Q4 2024 Reduced 93.27%
COGT Cogent Biosciences, Inc.	$526M	$0 0.0% of portfolio	4	Q4 2024 Added 33.33%
OCUL Ocular Therapeutix, Inc	$539M	$0 0.0% of portfolio	4	Q4 2024 Added 33.33%
OLMA Olema Pharmaceuticals, Inc.	$202M	$0 0.0% of portfolio	150	Q4 2024 New
PTGX Protagonist Therapeutics, Inc	$1.9B	$0 0.0% of portfolio	7	Q4 2024 New
SANA Sana Biotechnology, Inc.	$573M	$0 0.0% of portfolio	5	Q4 2024 Added 66.67%
STTK Shattuck Labs, Inc.	$58.1M	$0 0.0% of portfolio	328	Q4 2024 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	473	Q4 2024 New
VIGL Vigil Neuroscience, Inc.	$85.7M	$0 0.0% of portfolio	313	Q4 2024 Added 58.08%
HOWL Werewolf Therapeutics, Inc.	$40.8M	$0 0.0% of portfolio	414	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.